Georgia's cannabis program stands at a critical crossroads. Despite being established in 2015, the state's medical cannabis framework remains one of the most restrictive in the nation, limiting both product types and patient access. But could this cautious approach actually provide advantages?

During a recent Qredible Live broadcast, Judson Hill, Georgia Market President of Fine Fettle and one of only six licensed medical cannabis operators in the state, shared valuable insights on Georgia's current cannabis landscape and where the industry is headed. This discussion highlighted how Georgia's position as a late adopter creates unique opportunities to learn from other states' successes and challenges.

Georgia's Current Medical Cannabis Framework

Georgia's medical cannabis program has remained relatively unchanged since its inception nearly a decade ago. As Hill explained, "Our program is still a low THC oil to answer your question and it's a very limited medical program both in terms of the products that we can offer and what it takes to be a qualifying patient."

One of the most restrictive aspects of Georgia's program is its requirement for qualifying conditions to be "severe or end-stage." Hill described this as "pretty inhumane" compared to other states where simply having a qualifying condition is sufficient for a doctor to recommend cannabis treatment.

"Georgia, unlike really any other state that I know, has a caveat that requires you not only to have the condition like cancer per se, but also it be severe or end-stage," Hill noted. This significantly limits the number of patients who can access medical cannabis, even when they might benefit from it.

Current products are also restricted to low THC oil containing no more than 5% THC, further limiting treatment options compared to other medical cannabis states.

Lessons from Other Markets

Hill's extensive background in multiple cannabis markets, including California and Massachusetts, gives him a unique perspective on what Georgia can learn from states with more established programs.

One positive aspect of Georgia's approach is its tax structure. "Right now our products are not taxed any differently than any other retail product in the jurisdiction we're in. So there's not a cannabis excise tax or anything like that," Hill explained. "The legislature has said okay this is medicine we are not going to then tax it as a sin product which is what you see in most other recreational states."

Regarding supply chain issues, Hill noted how Georgia's vertically integrated model offers significant advantages for medical patients: "When your focus is on making a consistent, reliable product, you need to have the same inputs every time and have that dialed in." He contrasted this with more open markets like California where quality control can be challenging because "every input could be different depending on which batch of product you get."

Hill also touched on how Georgia has avoided problematic tracking systems: "In Georgia we don't have a track and trace system which is unique...the regulators have visibility directly into our solutions which I think actually provides a lot better reality of what's going on."

Recent Developments and Future Opportunities

A significant development for Georgia's cannabis program is the recent announcement of a blue ribbon study committee established by the Speaker of the House. This committee will focus on educating legislators about both medical cannabis and hemp.

"I think the speaker has clearly taken it upon himself and the legislature to prioritize the education of both medical cannabis and hemp," Hill said. "We're really excited about that study committee and participating in that over the summer so that we can pass some legislation next year that is based on science and understanding."

This educational initiative reflects a changing attitude among Georgia lawmakers. As Hill noted, "It's becoming less of a niche radical issue in the legislature and more mainstream as folks get educated."

Two bills that moved forward in the recent legislative session but ultimately stalled—SB220 and HB227—will be up for consideration again next year, potentially expanding the program to better serve patients.

Balance Medical Focus with Wellness Applications

Looking ahead, Hill envisions a future where Georgia maintains its medical focus through regulated dispensaries while allowing hemp products to serve wellness and recreational needs.

"I think there's a variety of ways that cannabis can be helpful, not just to the severe and end-stage people," Hill explained. "I think there's more just ways to improve your health and lifestyle."

The state has already taken steps in this direction with its hemp regulations. In 2024, Georgia passed a bill requiring retailers, manufacturers, and distributors to register with the Department of Agriculture, while simultaneously outlawing unintended products like THCA.

Hill praised this approach: "They've done a great job of being one of the first states to put in proper regulations for hemp that didn't kill the whole industry, but also didn't allow for a free-for-all."

The Path Forward for Georgia's Medical Cannabis Program

Georgia's cautious approach to cannabis has resulted in a highly restricted medical program, but it also positions the state to learn from the experiences of earlier adopters. With increased educational efforts through the new study committee and growing acceptance among legislators, Georgia has the opportunity to develop a program that maintains medical quality standards while expanding access to patients who could benefit.

As Hill put it, "Why cannabis was first made legal across the country was for medical benefits and putting the focus back on the patients is really what we're about at Fine Fettle and what the Georgia program needs to be about."

The coming year will be pivotal for Georgia's cannabis program as lawmakers consider new legislation informed by both science and the experiences of other states. For patients and industry stakeholders alike, these developments represent hope for a more accessible and effective medical cannabis program in the Peach State.